Pancreatic stent, covered, metallic, removable: medical device reports filed with FDA

2,148 reports carry this product code, 2014–2026; 3 brands with a page.

Read first · FDA's statement on these data

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product. openFDA, FDA

FDA adds: "Although MDRs are a valuable source of information, this passive surveillance system has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data. In addition, the incidence or prevalence of an event cannot be determined from this reporting system alone due to potential under-reporting of events and lack of information about frequency of device use." And: "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices."

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

2,148
reports with this product code: 0% of all MAUDE reports; 333
reports, 12 months to August 2026: 303 in the 12 months before; 44%
classified as malfunction: 62.3% across all reports; 3%
classified as death, as reported: 0.9% across all reports

Product code PCU is FDA's classification for "Pancreatic stent, covered, metallic, removable" (gastroenterology, Urology panel), a class 2 device. 2,148 medical device reports carry this product code, 0% of the MAUDE database, from July 2014 to August 2026.

333 reports arrived in the 12 months to August 2026, up 10% from 303 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (52.8%), malfunction (44%) and death (3%). 3 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

Brand	Reports	Latest 12 months	Classified as death	Classified as malfunction
AXIOS Stent and Electrocautery Enhanced Delivery System	1,306	495	3.5%	48.9%
Axios Stent And Delivery System	484	0	4.3%	30.6%
Axios?	311	224	1.5%	51%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)	Reports	Share
Boston Scientific - Marlborough	111	5.2%
Boston Scientific - Galway	93	4.3%

Reports by month, five years

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death3%65

Injury52.8%1,135

Malfunction44%946

Other0%1

Not given0%1

Who filed

Manufacturer report98.4%2,113

Voluntary report0.7%16

User facility report0%0

Distributor report0%0

Not given0.9%19

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)	Reports	Share
Positioning problem	462	21.5%
Activation, positioning or separation problem	356	16.6%
Positioning failure	346	16.1%
Activation failure	319	14.9%
Migrationthe device moved from where it was placed	145	6.8%
Premature activation	140	6.5%
Breakthe device broke	130	6.1%
Detachment of device or device componentpart of the device came off	97	4.5%
Difficult to removethe device was hard to remove	97	4.5%
Entrapment of device	90	4.2%
Difficult or delayed positioning	84	3.9%
Electrical /electronic property probleman electrical or electronic problem	76	3.5%
Material integrity problema problem with the device material	55	2.6%
Device stenosis	54	2.5%
Difficult to advance	49	2.3%
Material deformation	42	2%
Migration or expulsion of device	39	1.8%
Human-device interface problem	28	1.3%
Device-device incompatibility	26	1.2%
Failure to conduct	26	1.2%

Questions about pancreatic stent, covered, metallic, removable reports

What is product code PCU?

FDA's classification code for "Pancreatic stent, covered, metallic, removable", class 2, reviewed by the gastroenterology, Urology panel. Every device report carries the product code of the device involved.

How many reports carry this code?

2,148 reports through August 2026, 333 of them in the latest 12 months.

Which brands appear most often?

AXIOS Stent and Electrocautery Enhanced Delivery System (1,306), Axios Stent And Delivery System (484) and Axios? (311). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.